Myovant Sciences Ltd. Pre-Tax Income
Myovant Sciences Ltd. reported Pre-Tax Income of -$56.42 million for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2023-01-26
- Myovant Sciences Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-12-31 was -$56.42M.
- Myovant Sciences Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-09-30 was -$37.51M.
- Myovant Sciences Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-06-30 was -$13.07M.
- Myovant Sciences Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-03-31 was -$55.30M.
- Myovant Sciences Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$200.93M.
- Myovant Sciences Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2021 was -$254.80M.
- Myovant Sciences Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$288.23M.
- Myovant Sciences Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2019 was -$273.07M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | -$56.42M 10-Q · filed 2023-01-26 | -$93.93M derived: sum of 2 quarters · filed 2023-01-26 | -$107.00M 10-Q · filed 2023-01-26 | -$162.30M derived: sum of 4 quarters · filed 2023-01-26 | |
| 2022-09-30 | -$37.51M 10-Q · filed 2022-10-26 | -$50.58M 10-Q · filed 2022-10-26 | -$105.88M derived: sum of 3 quarters · filed 2022-10-26 | -$169.03M derived: sum of 4 quarters · filed 2023-01-26 | |
| 2022-06-30 | -$13.07M 10-Q · filed 2022-07-27 | -$68.37M derived: sum of 2 quarters · filed 2022-07-27 | -$131.52M derived: sum of 3 quarters · filed 2023-01-26 | -$153.26M derived: sum of 4 quarters · filed 2023-01-26 | |
| 2022-03-31 | -$55.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | -$118.44M derived: sum of 2 quarters · filed 2023-01-26 | -$140.18M derived: sum of 3 quarters · filed 2023-01-26 | -$200.93M 10-K · filed 2022-05-11 | |
| 2021-12-31 | -$63.15M 10-Q · filed 2023-01-26 | -$84.89M derived: sum of 2 quarters · filed 2023-01-26 | -$145.64M 10-Q · filed 2023-01-26 | -$226.05M derived: sum of 4 quarters · filed 2023-01-26 | |
| 2021-09-30 | -$21.74M 10-Q · filed 2022-10-26 | -$82.49M 10-Q · filed 2022-10-26 | -$162.90M derived: sum of 3 quarters · filed 2022-10-26 | -$237.90M derived: sum of 4 quarters · filed 2022-10-26 | |
| 2021-06-30 | -$60.75M 10-Q · filed 2022-07-27 | -$141.16M derived: sum of 2 quarters · filed 2022-07-27 | -$216.16M derived: sum of 3 quarters · filed 2022-07-27 | -$283.36M derived: sum of 4 quarters · filed 2022-07-27 | |
| 2021-03-31 | -$80.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | -$155.41M derived: sum of 2 quarters · filed 2022-05-11 | -$222.61M derived: sum of 3 quarters · filed 2022-05-11 | -$254.80M 10-K · filed 2022-05-11 | |
| 2020-12-31 | -$75.00M 10-Q · filed 2022-01-26 | -$142.20M derived: sum of 2 quarters · filed 2022-01-26 | -$174.39M 10-Q · filed 2022-01-26 | -$239.24M derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-09-30 | -$67.20M 10-Q · filed 2021-10-26 | -$99.38M 10-Q · filed 2021-10-26 | -$164.24M derived: sum of 3 quarters · filed 2022-05-11 | -$249.65M derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-06-30 | -$32.19M 10-Q · filed 2021-07-28 | -$97.04M derived: sum of 2 quarters · filed 2022-05-11 | -$182.45M derived: sum of 3 quarters · filed 2022-05-11 | -$252.82M derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-03-31 | -$64.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | -$150.26M derived: sum of 2 quarters · filed 2022-05-11 | -$220.64M derived: sum of 3 quarters · filed 2022-05-11 | -$288.23M 10-K · filed 2022-05-11 | |
| 2019-12-31 | -$85.41M 10-Q · filed 2021-02-11 | -$155.79M derived: sum of 2 quarters · filed 2021-02-11 | -$223.38M 10-Q · filed 2021-02-11 | ||
| 2019-09-30 | -$70.37M 10-Q · filed 2020-11-12 | -$137.96M 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | -$67.59M 10-Q · filed 2020-08-11 | ||||
| 2019-03-31 | -$273.07M 10-K · filed 2021-05-11 | ||||
| 2018-03-31 | -$143.04M 10-K · filed 2020-05-18 | ||||
| 2017-03-31 | -$83.51M 10-K · filed 2019-05-24 | ||||
| 2016-03-31 | -$1.66M 10-K · filed 2018-06-07 |